As of April 16, 2025, Foghorn Therapeutics (FHTX) has a market cap of $0.19 billion USD. According to our data, Foghorn Therapeutics is ranked No.7028 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.19 B |
-27.86%
|
Dec 31, 2024 | $0.26 B |
-26.82%
|
Dec 29, 2023 | $0.36 B |
1.10%
|
Dec 30, 2022 | $0.35 B |
-72.10%
|
Dec 31, 2021 | $1.27 B |
12.83%
|
Dec 31, 2020 | $1.13 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Sage Therapeutics
SAGE
|
$0.46 B |
-7.378 M
|
![]() USA
|
![]() Relay Therapeutics
RLAY
|
$0.44 B |
-0.029 B
|
![]() USA
|
![]() Blueprint Medicines
BPMC
|
$5.16 B |
-0.043 B
|
![]() USA
|
![]() Revolution Medicines
RVMD
|
$6.72 B |
-0.028 B
|
![]() USA
|
![]() Kura Oncology
KURA
|
$0.48 B |
-4.039 M
|
![]() USA
|
![]() Zentalis Pharmaceuticals
ZNTL
|
$90.84 M |
-0.359 M
|
![]() USA
|
![]() IDEAYA Biosciences
IDYA
|
$1.45 B |
-0.037 B
|
![]() USA
|
![]() G1 Therapeutics
GTHX
|
$0.38 B |
0.000 M
|
![]() USA
|
![]() Syros Pharmaceuticals
SYRS
|
$0.70 M |
0.000 M
|
![]() USA
|
![]() Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
![]() USA
|
Market Cap | = | FHTX Stock Price | * | FHTX Shares Outstanding |
= | $3.40 | * | 55.61 M | |
= | $0.19 B |